EQUITY - Embodiment, social ineQualities, lifecoUrse epidemiology, cancer and chronIc diseases, intervenTions, methodologY

Equipe constitutive du CERPOP, UMR 1295, unité mixte INSERM - Université Toulouse III Paul Sabatier
 




2022
  1. Bouhanick B, Brusq C, Bongard V, Tessier S, Montastruc JL, Senard JM, Montastruc F, Herin F. Blood pressure measurements after mRNA-SARS-CoV-2 tozinameran vaccination: a retrospective analysis in a university hospital in France. J Hum Hypertens. 2022 Jun;36(6):580-581. doi: 10.1038/s41371-021-00634-0.
     
  2. Conte C, Vayr F, Pajiep MC, Despas F, Huguet F, Mestre ML, Gauthier M, Herin F. Impact of the treatment of chronic myeloid leukaemia by tyrosine-kinase inhibitors on sick leaves refund: a nationwide cohort study. Support Care Cancer. 2022 Jun;30(6):5431-5440. doi: 10.1007/s00520-022-06968-w.
     
  3. Dimeglio C, Herin F, Da-Silva I, Gernigon C, Porcheron M, Chapuy-Regaud S, Izopet J. Decreased Efficiency of Neutralizing Antibodies from Previously Infected or Vaccinated Individuals against the B.1.617.2 (Delta) SARS-CoV-2 Variant. Microbiol Spectr. 2022 Aug 31;10(4):e0270621. doi: 10.1128/spectrum.02706-21.
     
  4. Dimeglio C, Herin F, Martin-Blondel G, Miedougé M, Izopet J. Antibody titers and protection against a SARS-CoV-2 infection. J Infect. 2022 Feb;84(2):248-288. doi: 10.1016/j.jinf.2021.09.013.
     
  5. Dimeglio C, Migueres M, Chapuy-Regaud S, Da-Silva I, Jougla I, Pradere C, Porcheron M, Martin-Blondel G, Lougarre C, Herin F, Izopet J. Comparative effects of mRNA vaccine booster and natural Omicron infection on the neutralizing antibody response. J Infect. 2022 Jul;85(1):e4-e6. doi: 10.1016/j.jinf.2022.05.001.
     
  6. Dimeglio C, Trémeaux P, Herin F, Da-Silva I, Porcheron M, Martin-Blondel G, Gernigon C, Chapuy-Regaud S, Villars H, Izopet J. Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population. J Infect. 2022 Dec;85(6):702-769. doi: 10.1016/j.jinf.2022.08.040.
     
  7. Dimeglio C, Migueres M, Bouzid N, Chapuy-Regaud S, Gernigon C, Da-Silva I, Porcheron M, Martin-Blondel G, Herin F, Izopet J. Antibody Titers and Protection against Omicron (BA.1 and BA.2) SARS-CoV-2 Infection. Vaccines (Basel). 2022 Sep 17;10(9):1548. doi: 10.3390/vaccines10091548.
     
  8. Dimeglio C, Herin F, Da-Silva I, Porcheron M, Martin-Blondel G, Chapuy-Regaud S, Izopet J. Post-Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Kinetics and Protection Duration. Clin Infect Dis. 2022 Aug 24;75(1):e924-e925. doi: 10.1093/cid/ciab984.

2021
  1. Bouhanick B, Montastruc F, Tessier S, Brusq C, Bongard V, Senard JM, Montastruc JL, Herin F. Hypertension and Covid-19 vaccines: are there any differences between the different vaccines? A safety signal. Eur J Clin Pharmacol. 2021 Dec;77(12):1937-1938. doi: 10.1007/s00228-021-03197-8.
     
  2. Dimeglio C, Herin F, Da-Silva I, Porcheron M, Martin-Blondel G, Chapuy-Regaud S, Izopet J. Post-vaccination SARS-CoV-2 antibody kinetics and protection duration. Clin Infect Dis. 2021 Nov 27:ciab984. doi: 10.1093/cid/ciab984. Epub ahead of print.
     
  3. Dimeglio C, Herin F, Da-Silva I, Jougla I, Pradere C, Porcheron M, Martin-Blondel G, Chapuy-Regaud S, Izopet J. Heterologous ChAdOx1-S/BNT162b2 vaccination: neutralizing antibody response to SARS-CoV-2. Clin Infect Dis. 2021 Aug 12:ciab705. doi: 10.1093/cid/ciab705.
     
  4. Dimeglio C, Herin F, Da-Silva I, Porcheron M, Martin-Blondel G, Miedougé M, Izopet J. Strong SARS-CoV-2-neutralizing antibody response of previously-infected healthcare workers given one dose of mRNA vaccine. Clin Infect Dis. 2021 Jun 22:ciab573. doi: 10.1093/cid/ciab573. Epub ahead of print.
     
  5. Dimeglio C, Herin F, Martin-Blondel G, Miedougé M, Izopet J. Antibody titers and protection against a SARS-CoV-2 infection. J Infect. 2021 Sep 21:S0163-4453(21)00483-7. doi: 10.1016/j.jinf.2021.09.013. Epub ahead of print.
     
  6. Dimeglio C, Herin F, Miedougé M, Cambus JP, Abravanel F, Mansuy JM, Soulat JM, Izopet J. Screening for SARS-CoV-2 antibodies among healthcare workers in a university hospital in southern France. J Infect. 2021 Jan;82(1):e29-e32. doi: 10.1016/j.jinf.2020.09.035.
     
  7. Dimeglio C, Herin F, Miedougé M, Martin-Blondel G, Soulat JM, Izopet J. Protection of Healthcare Workers Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection. Clin Infect Dis. 2021 Oct 5;73(7):1323-1324. doi: 10.1093/cid/ciab069.
     
  8. Dimeglio C, Loubes JM, Miedougé M, Herin F, Soulat JM, Izopet J. The real seroprevalence of SARS-CoV-2 in France and its consequences for virus dynamics. Sci Rep. 2021 Jun 15;11(1):12597. doi: 10.1038/s41598-021-92131-0.
     
  9. Herin F, Othenin J, Jouanjus E, Rousseau V, Niezborala M, Lapeyre-Mestre M. Evolution of medication consumption in a working environment in France: Results of the four waves of the "Drugs and Work" study (1986-2016). Pharmacoepidemiol Drug Saf. 2021 May;30(5):661-668. doi: 10.1002/pds.5211.
     
  10. Hérin F, Savall F, Saint-Martin P, Telmon N. Réparation du dommage en cancérologie [Compensation of damage in cancerology]. Bull Cancer. 2021 Apr;108(4):352-358. French. doi: 10.1016/j.bulcan.2020.11.021.
     
  11. Matrat M, Gain M, Haioun C, Le Bras F, Nisse C, Morschhauser F, Clin B, Baldi I, Verdun-Esquer C, Garnier R, Laborde-Castérot H, Hérin F, Esquirol Y, Andujar P, Belacel M, Chouaïd C, Chauvet C, Lasfargues G, Pairon JC. Development of a Questionnaire for the Search for Occupational Causes in Patients with Non-Hodgkin Lymphoma: The RHELYPRO Study. Int J Environ Res Public Health. 2021 Apr 11;18(8):4008. doi: 10.3390/ijerph18084008.
2020
  1. Vayr F, Montastruc M, Savall F, Despas F, Judic E, Basso M, Dunet C, Dalenc F, Laurent G, Soulat JM, Herin F. Work adjustments and employment among breast cancer survivors: a French prospective study. Support Care Cancer. 2020 Jan;28(1):185-192. doi: 10.1007/s00520-019-04799-w.
2019
  1. De Barros S, Vayr F, Despas F, Strumia M, Podevin C, Gauthier M, Delabesse E, Soulat JM, Laurent G, Huguet F, Herin F. The impact of chronic myeloid leukemia on employment: the French prospective study. Ann Hematol. 2019 Mar;98(3):615-623. doi: 10.1007/s00277-018-3549-5.
     
  2. Vayr F, Herin F, Jullian B, Soulat JM, Franchitto N. Barriers to seeking help for physicians with substance use disorder: A review. Drug Alcohol Depend. 2019 Jun 1;199:116-121. doi: 10.1016/j.drugalcdep.2019.04.004.
     
  3. Vayr F, Montastruc M, Savall F, Despas F, Judic E, Basso M, Dunet C, Dalenc F, Laurent G, Soulat JM, Herin F. Work adjustments and employment among breast cancer survivors: a French prospective study. Support Care Cancer. 2020 Jan;28(1):185-192. doi: 10.1007/s00520-019-04799-w.
     
  4. Vayr F, Savall F, Bigay-Game L, Soulat JM, Chouaid C, Herin F. Lung cancer survivors and employment: A systematic review. Lung Cancer. 2019 May;131:31-39. doi: 10.1016/j.lungcan.2019.03.010.